Gemifloxacin mesylate: UV spectrophotometric method for quantitative determination using experimental design for robustness
AUTOR(ES)
Paim, Clésio Soldateli, Führ, Fernanda, Steppe, Martin, Schapoval, Elfrides Eva Scherman
FONTE
Química Nova
DATA DE PUBLICAÇÃO
2012
RESUMO
This study describes the validation of UV spectrophotometric method for quantitative determination of gemifloxacin mesylate (GFM) in tablets using methanol as solvent. The method was specific, linear, precise, exact and robust at 272 and 343 nm. The results confirmed that the method in both wavelengths is valid and useful to the routine quality control of GFM in coated tablets. The validate method was compared to liquid chromatography (HPLC), microbiological assay and visible (VIS) spectrophotometry, which were previously developed and validated to the same drug. There was not significative difference between the methods for GFM quantitation.
Documentos Relacionados
- UV derivative spectrophotometric method for determination of estradiol valerate in tablets
- Development and validation of an UV spectrophotometric method for the determination of aliskiren in tablets
- Development and validation of UV spectrophotometric method for determination of levofloxacin in pharmaceutical dosage forms
- Development and validation of an UV-derivative spectrophotometric method for determination of glimepiride in tablets
- Indirect spectrophotometric method for determination of captopril using Cr(VI) and diphenylcarbazide